latanoprost

latanoprost /la·tan·o·prost/ (lah-tan´o-prost″) an antiglaucoma agent applied topically to the conjunctiva in the treatment of open-angle glaucoma and ocular hypertension.

latanoprost

[lah-tan′o-prost′]

an agent applied topically to the conjunctiva for treatment of open-angle glaucoma and ocular hypertension.

latanoprost [lah-tan´o-prost″]

an agent applied topically to the conjunctiva in treatment of open-angle glaucoma and ocular hypertension.

latanoprost

a prostaglandin F_2alpha analog used topically to reduce intraocular pressure in the treatment of glaucoma in dogs.

prostaglandin analogues

Drugs used in the treatment of open-angle glaucoma or ocular hypertension. At specific dosages they lower the intraocular pressure (IOP), supposedly by increasing the outflow of aqueous humour via the uveoscleral pathway. Common agents include latanoprost, travoprost, bimatoprost (a synthetic prostamide structurally related to prostaglandin) and unoprostone isopropyl. Bimatoprost reduces IOP by increasing the uveoscleral outflow as well as the trabecular outflow.

latanoprost

Xalatan^™ Ophthalmology An agent used to ↓ intraocular pressure in Pts with 1º and 2º glaucoma. See Glaucoma.

Mentioned in	?		References in periodicals archive	?		Medical browser	?		Full browser	?
beta-adrenergic blocking agent beta-blocker betaxolol hydrochloride bimatoprost glaucoma levobunolol hydrochloride prostaglandin analogues secondary deviation timolol maleate travoprost Xalatan	Again, the agent demonstrated an eye pressure-lowering effect, but any favorable result was obtained from a non-inferiority study in which DE-085 was compared with latanoprost. Santen Pharmaceutical Announces Results of Overseas Clinical Trials ... by JCNN News Summaries In a comment for clients, Robert Uhl, an analyst at Salomon Brothers, said, ``In our view, Allergan's existing businesses in ophthalmic products would provide a strong vehicle for Pharmacia & Upjohn to launch its soon-to-be-introduced therapy for glaucoma, Latanoprost. ALLERGAN, UPJOHN END MERGER TALKS by Daily News (Los Angeles, CA) AR-12286 may have broad implications in glaucoma therapy and could offer the next major advancement in the field since the approval of latanoprost (Xalatan) in 1996. Aerie Pharmaceuticals' ROCK Inhibitor, AR-12286, Demonstrates ... by Business Wire	Laser Whitening Laser-assisted in situ keratomileusis laser-assisted in-situ keratomileusis laserpuncture Lasette lash Lashley LASIK lasiocarpine Lasiosiphon Lasiospermum bipinnatum Lasix lasolocid Lassa fever Lassa fever virus Lassa virus lassitude lasso last last menstrual period last sacraments last will and testament LAT Latah latamoxef latanoprost Latchkey Child latchkey children Latchkey Kid LATE late abortion late bloom Late dumping syndrome late dyspituitary eunuchism Late Life Parent late luteal phase dysphoric disorder late phase reaction late potential late rickets late stent thrombosis late systole late systolic murmur late-onset diabetes late-onset immune deficiency late-phase hypersensitivity reaction late-term late-term abortion latebra latency latency period latency stage	Latada Latada LATADS Latæ Sententiæ Latæ Sententiæ Latæ Sententiæ LATAF LATAG LATAGS latah latah Latah County Latah County Youth Advocacy Council Latah County, ID Latah County, Idaho Latah Soil and Water Conservation District latakia latakia Latakiyah Latakiyah Latalpha Latalpha LATAM LATAM Latamoxef LATAN Latania latanier latanier latanier palm latanoprost LATAR LATARS LATAS LATAS LATAS Latastea Latastea Latasteopara Latasteopara LATB LATBR LATC LATCC LATCF latch latch latch latch latch Latch (electronics) latch bolt Latch Growth Factor Latch Insertion Delay Latch key kids Latch Logic Clock Generator latch needle latch on latch on latch onto latch plate

Mentioned in

References in periodicals archive

Medical browser

Full browser

beta-adrenergic blocking agent
beta-blocker
betaxolol hydrochloride
bimatoprost
glaucoma
levobunolol hydrochloride
prostaglandin analogues
secondary deviation
timolol maleate
travoprost
Xalatan

Again, the agent demonstrated an eye pressure-lowering effect, but any favorable result was obtained from a non-inferiority study in which DE-085 was compared with latanoprost.

Santen Pharmaceutical Announces Results of Overseas Clinical Trials ... by JCNN News Summaries

In a comment for clients, Robert Uhl, an analyst at Salomon Brothers, said, ``In our view, Allergan's existing businesses in ophthalmic products would provide a strong vehicle for Pharmacia & Upjohn to launch its soon-to-be-introduced therapy for glaucoma, Latanoprost.

ALLERGAN, UPJOHN END MERGER TALKS by Daily News (Los Angeles, CA)

AR-12286 may have broad implications in glaucoma therapy and could offer the next major advancement in the field since the approval of latanoprost (Xalatan) in 1996.

Aerie Pharmaceuticals' ROCK Inhibitor, AR-12286, Demonstrates ... by Business Wire